AFFI Statement on the Update to FDA’s Proposed Restructuring of the Human Foods Program and Office of Regulatory Affairs
Dr. Donna Garren, executive vice president of science and policy, issued the following statement in response to the FDA’s proposed restructuring of the Human Foods Program and Office of Regulatory Affairs: “While AFFI has supported